Xenagos Bio
Philadelphia, US · Founded 2025 · Delaware corporation
Founders & leadership
MJ
Michael J. McElhaughExecutive
Board
AD
Abel De La RosaBoard director
PH
Patrick HigginsBoard director
Reported raises · per SEC filings
Form D private placements$2.5M disclosed across 1 round · 2026
▶$2.5MraisedMay 2026 · 23 investors · BiotechnologyRule 506(b)
▶$2.5MraisedMay 2026 · 23 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Abel De La RosaDirector
- Michael J. McElhaughExecutive Officer, Director
- Patrick HigginsDirector
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Xenagos Bio raised?
- Xenagos Bio has disclosed $2.5M raised across 1 round.
- Where is Xenagos Bio headquartered?
- Xenagos Bio is headquartered in Philadelphia, US.